FindTrial
Sign In

Survey on How the Implementation of a Hypertension Digital Therapeutic in Medical Facilities Affects Patients' Healthcare Utilization

Survey on How the Implementation of a Hypertension Digital Therapeutic in Medical Facilities Affects Patients' Healthcare Utilization - Survey on How the Implementation of a Hypertension Digital Therapeutic in Medical Facilities Affects Patients' Healthcare Utilization

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000060168
Enrollment
600
Registered
2025-12-22
Start date
2025-12-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

None listed

Sponsors

CureApp, Inc.
Lead Sponsor
Self funding
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Questionnaire A (General Hypertension Patients):Adult hypertension patients who meet the diagnostic criteria for hypertension and are currently receiving treatment at a medical institution or have received treatment in the past. Survey B (Hypertension Patients Using SaMD):Currently undergoing hypertension treatment using CureApp HT and has received guidance from a physician at least once based on their own input.

Exclusion criteria

Exclusion criteria: Survey A (General Hypertension Patients):Patients who have received treatment with CureApp HT in the past or currently. Survey B (Hypertension Patients Using SaMD):-

Countries

Japan

Contacts

Public ContactYumi Hirayama

CureApp, Inc. Medical Division

ht_medical-affairs@cureapp.jp0362310183

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026